Deutsche Bank restated their buy rating on shares of Reckitt Benckiser Group (LON:RB) in a report released on Wednesday, Borsen Zeitung reports. They currently have a GBX 8,400 ($103.37) price target on the stock.
A number of other equities research analysts have also issued reports on the company. Kepler Capital Markets upped their price target on Reckitt Benckiser Group from GBX 6,700 ($82.45) to GBX 7,250 ($89.22) and gave the company a buy rating in a research report on Monday, May 4th. DZ Bank upped their price target on Reckitt Benckiser Group from GBX 7,100 ($87.37) to GBX 7,800 ($95.99) and gave the company a buy rating in a research report on Thursday, May 28th. Jefferies Financial Group set a GBX 6,600 ($81.22) price target on Reckitt Benckiser Group and gave the company a neutral rating in a research report on Tuesday, July 28th. Societe Generale dropped their price target on Reckitt Benckiser Group from GBX 5,400 ($66.45) to GBX 5,200 ($63.99) and set a sell rating for the company in a research report on Thursday, June 4th. Finally, UBS Group restated a buy rating and issued a GBX 8,400 ($103.37) price target on shares of Reckitt Benckiser Group in a research report on Monday, July 27th. Two research analysts have rated the stock with a sell rating, four have given a hold rating and thirteen have assigned a buy rating to the company’s stock. The company presently has an average rating of Buy and a consensus price target of GBX 7,655.56 ($94.21).
RB stock opened at GBX 7,706 ($94.83) on Wednesday. The company has a debt-to-equity ratio of 130.80, a current ratio of 0.56 and a quick ratio of 0.40. The business has a 50 day simple moving average of GBX 7,441.20 and a 200-day simple moving average of GBX 6,629.16. The firm has a market capitalization of $54.80 billion and a PE ratio of -14.83. Reckitt Benckiser Group has a 1 year low of GBX 73.44 ($0.90) and a 1 year high of GBX 8,191.30 ($100.80).
In other news, insider Nicandro Durante purchased 165 shares of the firm’s stock in a transaction on Wednesday, May 27th. The shares were bought at an average cost of GBX 6,884 ($84.72) per share, for a total transaction of £11,358.60 ($13,978.10).
Reckitt Benckiser Group Company Profile
Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.
Further Reading: Are all No-Load Funds Equal?
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.